Geode Capital Management
CAMP icon

Geode Capital Management’s CAMP4 Therapeutics CAMP Stock Holding History

Geode Capital Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
795,651
+412,830
+108% +$1.78M ﹤0.01% 3057
2026
Q1 		$1.69M Buy
382,821
+46,528
+14% +$221K ﹤0.01% 3189
2025
Q4 		$2.06M Buy
336,293
+275,922
+457% +$1.17M ﹤0.01% 3159
2025
Q3 		$181K Sell
60,371
-14,828
-20% -$27.5K ﹤0.01% 3956
2025
Q2 		$109K Sell
75,199
-84,403
-53% -$168K ﹤0.01% 4035
2025
Q1 		$638K Buy
159,602
+14,516
+10% +$70.2K ﹤0.01% 3458
2024
Q4 		$757K Buy
+145,086
New +$1.19M ﹤0.01% 3464

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management's CAMP Position: Q2 2026 in Review

Geode Capital Management increased its CAMP4 Therapeutics (CAMP) stake by 108% in Q2 2026, buying an estimated $1.78M and bringing the position to 795,651 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Geode Capital Management first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Geode Capital Management held 795,651 shares of CAMP4 Therapeutics worth $3.48M as of Q2 2026.
  • Geode Capital Management bought 412,830 CAMP4 Therapeutics shares in Q2 2026, an estimated $1.78M.
  • CAMP4 Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3057 holding.
  • Geode Capital Management first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.